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Abstract 
A 64-year-old Japanese woman had a lightly brown-blackish pigmented macule (1.2 cm 
in diameter) on the left sole of her foot. She received surgical excision following a 
diagnosis of acral lentiginous melanoma (ALM), which was confirmed 
histopathologically. One month after the operation, a second melanoma lesion was 
noticed adjacent to the grafted site. Histopathologically, the two lesions had no 
continuity, but HMB-45 and cyclin D1 double-positive cells were detected not only on 
aggregates of atypical melanocytes but also on single cells near the cutting edge of the 
first lesion. The unique occurrence of a sequential lesion of a primary melanoma might 
be caused by stimulated subclinical field cells during the wound healing process 
following the initial operation. This case warrants further investigation to establish the 
appropriate surgical margin of ALM lesions. 
 
Introduction 
Acral lentiginous melanoma (ALM) is the most common clinical type of melanoma in 
Orientals, accounting for 47% of all Japanese melanomas and for 27% of those located on 
the sole of the foot [1]. Local recurrences may be observed adjacent to the primary site 
following resection. We report a case of ALM, in which a second ALM adjacent to the 
primary site developed 1 month after resection, which was not recognized at the time of 
the initial operation.  
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Case Report 
A 64-year-old Japanese woman noticed a lightly brown-blackish pigmented macule (diameter: 1.2 
cm) on the sole of her left foot (fig. 1). Clinical examination revealed neither inguinal nor popliteal 
lymph node swelling. Dermoscopy disclosed a parallel ridge pattern with partial depigmented area (fig. 
2). Following the clinical diagnosis of ALM, tumor resection was performed with a 1.0-cm margin 
including deep fat tissue. Histological diagnosis was ALM in situ (fig. 3). One month after the first 
operation, however, another blackish macule was found 5 mm adjacent to the grafted margin (fig. 4a). 
The lesion rapidly enlarged to a 1.2-cm blackish variegated-colored macule (fig. 4b); dermoscopically, a 
multi-component pattern with parallel ridges, irregular dots and focal hypopigmentation was noted 
(fig. 5). Two months after the first operation, local excision for ALM was again performed with a 1.5-cm 
margin. Histopathology disclosed atypical melanocytes with papillary dermal invasion (fig. 6). The 
pathological staging of the second lesion was pT1aN0M0 (stage IA according to the UICC 2002 criteria – 
Breslow tumor thickness 0.5 mm and Clark level II). No recurrences or distant metastases have been 
detected 16 months after the second operation. HMB-45 and cyclin D1 double immunofluorescence 
staining of the first lesion disclosed double-positive cells not only on aggregates of atypical melanocytes 
but also on single cells near the cutting edge (fig. 7), indicating a proliferative potential of these cells. 
Double-positive cells were also detected in the second melanoma lesion (data not shown). 
Discussion 
We regard this case as a rare manifestation of sequential spread of primary melanomas. 
Initially, no clinically discernible lesion was noted at the site of the second melanoma (fig. 
1). Retrospective re-examination could not disclose any pigmented lesion at the time of 
the first operation. Careful histopathological examination also failed to reveal any 
continuity between the two lesions.  
The unique presentation of the development of the second melanoma in such a short 
period might be explained by the field cell model proposed by Bastian [2]. According to 
his model, field cells show genomic alterations despite the absence of histological or 
proliferative abnormalities. He reported cyclin D1 gene amplification in ALM lesions by 
fluorescent in situ hybridization (FISH). Our HMB-45 and cyclin D1 double 
immunofluorescence analysis is consistent with his hypothesis that the quiescent field 
cells might have been activated by various growth factors of the graft site during wound 
healing, leading to local ALM recurrence. Wound fluid contains various growth factors, 
e.g. epidermal growth factor, platelet-derived growth factor, vascular endothelial growth 
factor, fibroblast growth factor and transforming growth factor-β [3, 4]. North et al. [5] 
reported that 84% of acral melanomas contain FISH-detectable field cells, and in 5 of 19 
cases field cells were detected at the surgical margin. However, clinically local recurrence 
was not observed in their patients followed up for 12–94 months (mean 51 months).  
The surgical margin of melanoma is a matter of debate. To date, acral lesions have 
scarcely been studied in randomized controlled studies. The Japanese guidelines for 
cutaneous melanomas recommend a surgical margin of 0.5 cm for in situ lesions, 1.0 cm 
for melanomas <2 mm (Breslow thickness) and 2.0 cm for melanomas ≥2 mm (Breslow 
thickness). Due to the lack of a correlation between field cell spread and tumor depth or 
size [5], evidence for the appropriate surgical margin of ALM is still inconclusive. A 
possible effect of complete resection (including field cells) on overall survival or 
recurrence-free survival remains to be determined. However, our case, albeit rare, 
suggests that further studies in this context may help to establish the appropriate surgical 
margin of ALM lesions.  
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Fig. 1. Clinical appearance of the first lesion. A 1.0-cm brownish macule can be seen. Note: no second 
lesion is discernible on the lateral side. 
 
 
 
Fig. 2. Dermoscopy of the first lesion shows a parallel ridge pattern and focal hypopigmentation. 
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Fig. 3. Histopathology of the first lesion. Atypical melanocytes on the basal layer led to the diagnosis of 
ALM. No dermal invasion was detected. 
 
 
 
Fig. 4. Pigmented macule located 5 mm from the postgrafted scar. a Clinical appearance of the second 
lesion. A blackish macule was observed beside the first grafted site (on postoperative day 34). b Two 
months after the first operation, a 1.2-cm, ill-defined, irregularly shaped, blackish macule with color 
variegation was observed. 
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Fig. 5. Dermoscopy of the second lesion shows multiple components made of a parallel ridge 
pattern,with irregular distribution of small melanin dots and a focal hypopigmented component. 
 
 
 
Fig. 6. Histopathology of the second lesion. Atypical epidermal melanocytes are observed with 
papillary dermal invasion. 
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Fig. 7. Cytoplasmic HMB-45 (green) and nuclear cyclin D1 (red) double immunofluorescence staining. 
The aggregated melanocytes at the center of the first lesion (a) show double-positive staining. The single 
cell near the cutting edge (b) also shows double-positive staining. 
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